Structural remodeling of cardiac myocytes in patients with ischemic cardiomyopathy

A. Martin Gerdes, Scott E. Kellerman, Jo Ann Moore, Karl E. Muffly, Linda C. Clark, Phyllis Y. Reaves, Krystyna B. Malec, Peter P. McKeown, Douglas D. Schocken

Research output: Contribution to journalArticle

191 Citations (Scopus)

Abstract

Background. Chronic ischemic heart disease may lead to ventricular dilation and congestive heart failure (ischemic cardiomyopathy [ICM]). The changes in cardiac myocyte shape associated with this dilation, however, are not known. Methods and Results. Left ventricular myocyte dimensions were assessed in cells isolated from explanted human hearts obtained from patients with ICM (n=6) who were undergoing heart transplantation. Cells were also examined from three nonfailing donor hearts with normal coronary arteries (NCA). Compared with cells from patients with NCA, myocyte length was 40% longer in hearts from patients with ICM (197±8 versus 141±9 μm, p<0.01), cell width was not significantly different, and cell length/width ratio was 49% greater (11.2±0.9 versus 7.5±0.6, p<0.01). Sarcomere length was the same in myocytes from both groups. The extent of myocyte lengthening is comparable to the increase in end-diastolic diameter commonly reported in patients with ICM. Conclusions. These data suggest that increased myocyte length (an intracellular event), instead of myocyte slippage (an extracellular event), is largely responsible for the chamber dilation in ICM. Furthermore, maladaptive remodeling of myocyte shape (e.g., increased myocyte length/width ratio) may contribute to the elevated wall stress (e.g., increased chamber radius/wall thickness) in ICM.

Original languageEnglish (US)
Pages (from-to)426-430
Number of pages5
JournalCirculation
Volume86
Issue number2
DOIs
StatePublished - Aug 1992

Fingerprint

Cardiomyopathies
Cardiac Myocytes
Muscle Cells
Dilatation
Coronary Vessels
Sarcomeres
Heart Transplantation
Myocardial Ischemia
Heart Failure
Tissue Donors

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Gerdes, A. M., Kellerman, S. E., Moore, J. A., Muffly, K. E., Clark, L. C., Reaves, P. Y., ... Schocken, D. D. (1992). Structural remodeling of cardiac myocytes in patients with ischemic cardiomyopathy. Circulation, 86(2), 426-430. https://doi.org/10.1161/01.CIR.86.2.426

Structural remodeling of cardiac myocytes in patients with ischemic cardiomyopathy. / Gerdes, A. Martin; Kellerman, Scott E.; Moore, Jo Ann; Muffly, Karl E.; Clark, Linda C.; Reaves, Phyllis Y.; Malec, Krystyna B.; McKeown, Peter P.; Schocken, Douglas D.

In: Circulation, Vol. 86, No. 2, 08.1992, p. 426-430.

Research output: Contribution to journalArticle

Gerdes, AM, Kellerman, SE, Moore, JA, Muffly, KE, Clark, LC, Reaves, PY, Malec, KB, McKeown, PP & Schocken, DD 1992, 'Structural remodeling of cardiac myocytes in patients with ischemic cardiomyopathy', Circulation, vol. 86, no. 2, pp. 426-430. https://doi.org/10.1161/01.CIR.86.2.426
Gerdes AM, Kellerman SE, Moore JA, Muffly KE, Clark LC, Reaves PY et al. Structural remodeling of cardiac myocytes in patients with ischemic cardiomyopathy. Circulation. 1992 Aug;86(2):426-430. https://doi.org/10.1161/01.CIR.86.2.426
Gerdes, A. Martin ; Kellerman, Scott E. ; Moore, Jo Ann ; Muffly, Karl E. ; Clark, Linda C. ; Reaves, Phyllis Y. ; Malec, Krystyna B. ; McKeown, Peter P. ; Schocken, Douglas D. / Structural remodeling of cardiac myocytes in patients with ischemic cardiomyopathy. In: Circulation. 1992 ; Vol. 86, No. 2. pp. 426-430.
@article{afcf1d5bb5ca4a84a8af5c469c05efdc,
title = "Structural remodeling of cardiac myocytes in patients with ischemic cardiomyopathy",
abstract = "Background. Chronic ischemic heart disease may lead to ventricular dilation and congestive heart failure (ischemic cardiomyopathy [ICM]). The changes in cardiac myocyte shape associated with this dilation, however, are not known. Methods and Results. Left ventricular myocyte dimensions were assessed in cells isolated from explanted human hearts obtained from patients with ICM (n=6) who were undergoing heart transplantation. Cells were also examined from three nonfailing donor hearts with normal coronary arteries (NCA). Compared with cells from patients with NCA, myocyte length was 40{\%} longer in hearts from patients with ICM (197±8 versus 141±9 μm, p<0.01), cell width was not significantly different, and cell length/width ratio was 49{\%} greater (11.2±0.9 versus 7.5±0.6, p<0.01). Sarcomere length was the same in myocytes from both groups. The extent of myocyte lengthening is comparable to the increase in end-diastolic diameter commonly reported in patients with ICM. Conclusions. These data suggest that increased myocyte length (an intracellular event), instead of myocyte slippage (an extracellular event), is largely responsible for the chamber dilation in ICM. Furthermore, maladaptive remodeling of myocyte shape (e.g., increased myocyte length/width ratio) may contribute to the elevated wall stress (e.g., increased chamber radius/wall thickness) in ICM.",
author = "Gerdes, {A. Martin} and Kellerman, {Scott E.} and Moore, {Jo Ann} and Muffly, {Karl E.} and Clark, {Linda C.} and Reaves, {Phyllis Y.} and Malec, {Krystyna B.} and McKeown, {Peter P.} and Schocken, {Douglas D.}",
year = "1992",
month = "8",
doi = "10.1161/01.CIR.86.2.426",
language = "English (US)",
volume = "86",
pages = "426--430",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Structural remodeling of cardiac myocytes in patients with ischemic cardiomyopathy

AU - Gerdes, A. Martin

AU - Kellerman, Scott E.

AU - Moore, Jo Ann

AU - Muffly, Karl E.

AU - Clark, Linda C.

AU - Reaves, Phyllis Y.

AU - Malec, Krystyna B.

AU - McKeown, Peter P.

AU - Schocken, Douglas D.

PY - 1992/8

Y1 - 1992/8

N2 - Background. Chronic ischemic heart disease may lead to ventricular dilation and congestive heart failure (ischemic cardiomyopathy [ICM]). The changes in cardiac myocyte shape associated with this dilation, however, are not known. Methods and Results. Left ventricular myocyte dimensions were assessed in cells isolated from explanted human hearts obtained from patients with ICM (n=6) who were undergoing heart transplantation. Cells were also examined from three nonfailing donor hearts with normal coronary arteries (NCA). Compared with cells from patients with NCA, myocyte length was 40% longer in hearts from patients with ICM (197±8 versus 141±9 μm, p<0.01), cell width was not significantly different, and cell length/width ratio was 49% greater (11.2±0.9 versus 7.5±0.6, p<0.01). Sarcomere length was the same in myocytes from both groups. The extent of myocyte lengthening is comparable to the increase in end-diastolic diameter commonly reported in patients with ICM. Conclusions. These data suggest that increased myocyte length (an intracellular event), instead of myocyte slippage (an extracellular event), is largely responsible for the chamber dilation in ICM. Furthermore, maladaptive remodeling of myocyte shape (e.g., increased myocyte length/width ratio) may contribute to the elevated wall stress (e.g., increased chamber radius/wall thickness) in ICM.

AB - Background. Chronic ischemic heart disease may lead to ventricular dilation and congestive heart failure (ischemic cardiomyopathy [ICM]). The changes in cardiac myocyte shape associated with this dilation, however, are not known. Methods and Results. Left ventricular myocyte dimensions were assessed in cells isolated from explanted human hearts obtained from patients with ICM (n=6) who were undergoing heart transplantation. Cells were also examined from three nonfailing donor hearts with normal coronary arteries (NCA). Compared with cells from patients with NCA, myocyte length was 40% longer in hearts from patients with ICM (197±8 versus 141±9 μm, p<0.01), cell width was not significantly different, and cell length/width ratio was 49% greater (11.2±0.9 versus 7.5±0.6, p<0.01). Sarcomere length was the same in myocytes from both groups. The extent of myocyte lengthening is comparable to the increase in end-diastolic diameter commonly reported in patients with ICM. Conclusions. These data suggest that increased myocyte length (an intracellular event), instead of myocyte slippage (an extracellular event), is largely responsible for the chamber dilation in ICM. Furthermore, maladaptive remodeling of myocyte shape (e.g., increased myocyte length/width ratio) may contribute to the elevated wall stress (e.g., increased chamber radius/wall thickness) in ICM.

UR - http://www.scopus.com/inward/record.url?scp=0026693383&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026693383&partnerID=8YFLogxK

U2 - 10.1161/01.CIR.86.2.426

DO - 10.1161/01.CIR.86.2.426

M3 - Article

C2 - 1638711

AN - SCOPUS:0026693383

VL - 86

SP - 426

EP - 430

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 2

ER -